Regulated splicing of the fibronectin EDA exon is essential for proper skin wound healing and normal lifespan

Journal of Cell Biology

Volumn 162, Issue 1, 2003, Pages 149-160

  Muro, Andrés F ^a   Chauhan, Anil K ^a   Gajovic, Srecko ^b   Iaconcig, Alessandra ^a   Porro, Fabiola ^a   Stanta, Giorgio ^a,c   Baralle, Francisco E ^a  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

^b UNIVERSITY OF ZAGREB   (Croatia)

^c UNIVERSITY OF TRIESTE   (Italy)

Author keywords

Aging; Basal lamina; CRE loxP; ECM; Integrin receptors

Indexed keywords

FIBRONECTIN; GLYCOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EMBRYO DEVELOPMENT; EXON; GENE DELETION; HOMOZYGOSITY; LIFESPAN; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; RNA SPLICING; SEQUENCE HOMOLOGY; SKIN INJURY; WOUND HEALING;

AGING; ALTERNATIVE SPLICING; ANIMALS; CELLS, CULTURED; DOWN-REGULATION; EXONS; FETUS; FIBROBLASTS; FIBRONECTINS; GENE DELETION; GENE EXPRESSION REGULATION, DEVELOPMENTAL; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUTATION; PROTEIN ISOFORMS; PROTEIN STRUCTURE, TERTIARY; RNA, MESSENGER; SKIN; SURVIVAL RATE; WOUND HEALING;

ANIMALIA;

EID: 0038825157     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.200212079     Document Type: Article

References (60)

1. Boyle, D.L., Y. Shi, S. Gay, and G.S. Firestein. 2000. Regulation of CS1 fibronectin expression and function by IL-1 in endothelial cells. Cell. Immunol. 200:1-7.
2. Caputi, M., G. Casari, S. Guenzi, R. Tagliabue, A. Sidoli, C.A. Melo, and F.E. Baralle. 1994. A novel bipartite splicing enhancer modulates the differential processing of the human fibronectin EDA exon. Nucleic Acids Res. 22:1018-1022.
3. Caputi, M., F.E. Baralle, and C.A. Melo. 1995. Analysis of the linkage between fibronectin alternative spliced sites during ageing in rat tissues. Biochim. Biophys. Acta. 1263:53-59.
4. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
5. Clark, R.A., J.M. Lanigan, P. DellaPelle, E. Manseau, H.F. Dvorak, and R.B. Colvin. 1982. Fibronectin and fibrin provide a provisional matrix for epidermal cell migration during wound reepithelialization. J. Invest. Dermatol. 79:264-269.
6. Clark, R.A., H.J. Winn, H.F. Dvorak, and R.B. Colvin. 1983. Fibronectin beneath reepithelializing epidermis in vivo: sources and significance. J. Invest. Dermatol. 80:26s-30s.
7. DeSimone, D.W., P.A. Norton, and R.O. Hynes. 1992. Identification and characterization of alternatively spliced fibronectin mRNAs expressed in early Xenopus embryos. Dev. Biol. 149:357-369.
8. Du, H., M. Heur, M. Duanmu, G.A. Grabowski, D.Y. Hui, D.P. Witte, and J. Mishra. 2001. Lysosomal acid lipase-deficient mice: depletion of white and brown fat, severe hepatosplenomegaly, and shortened life span. J. Lipid Res. 42:489-500.
9. Du, K., Y. Peng, L.E. Greenbaum, B.A. Haber, and R. Taub. 1997. HRS/SRp40-mediated inclusion of the fibronectin EIIIB exon, a possible cause of increased EIIIB expression in proliferating liver. Mol. Cell. Biol. 17:4096-4104.
10. ffrench-Constant, C. 1995. Alternative splicing of fibronectin - many different proteins but few different functions. Exp. Cell Res. 221:261-271.
11. ffrench-Constant, C., and R.O. Hynes. 1989. Alternative splicing of fibronectin is temporally and spatially regulated in the chicken embryo. Development. 106:375-388.
12. ffrench-Constant, C., L. Van de Water, H.F. Dvorak, and R.O. Hynes. 1989. Reappearance of an embryonic pattern of fibronectin splicing during wound healing in the adult rat. J. Cell Biol. 109:903-914.
13. Fukuda, T., N. Yoshida, Y. Kataoka, R. Manabe, Y. Mizuno-Horikawa, M. Sato, K. Kuriyama, N. Yasui, and K. Sekiguchi. 2002. Mice lacking the EDB segment of fibronectin develop normally but exhibit reduced cell growth and fibronectin matrix assembly in vitro. Cancer Res. 62:5603-5610.
14. George, E.L., E.N. Georges-Labouesse, R.S. Patel-King, H. Rayburn, and R.O. Hynes. 1993. Defects in mesoderm, neural tube and vascular development in mouse embryos lacking fibronectin. Development. 119:1079-1091.
15. Georges-Labouesse, E.N., E.L. George, H. Rayburn, and R.O. Hynes. 1996. Mesodermal development in mouse embryos mutant for fibronectin. Dev. Dyn. 207:145-156.
16. Gimond, C., C. Baudoin, R. van der Neut, D. Kramer, J. Calafat, and A. Sonnenberg. 1998. Cre-loxP-mediated inactivation of the α6A integrin splice variant in vivo: evidence for a specific functional role of α6A in lymphocyte migration but not in heart development. J. Cell Biol. 143:253-266.
17. Goodrick, C.L. 1975. Life-span and the inheritance of longevity of inbred mice. J. Gerontol. 30:257-263.
18. Grinnell, F. 1984. Fibronectin and wound healing. J. Cell. Biochem. 26:107-116.
19. Guan, J.L., J.E. Trevithick, and R.O. Hynes. 1990. Retroviral expression of alternatively spliced forms of rat fibronectin. J. Cell Biol. 110:833-847.
20. Gutman, A., and A.R. Kornblihtt. 1987. Identification of a third region of cell-specific alternative splicing in human fibronectin mRNA. Proc. Natl. Acad. Sci. USA. 84:7179-7182.
21. Helgason, C.D., J.E. Damen, P. Rosten, R. Grewal, P. Sorensen, S.M. Chappel, A. Borowski, F. Jirik, G. Krystal, and R.K. Humphries. 1998. Targeted disruption of SHIP leads to hemopoietic perturbations, lung pathology, and a shortened life span. Genes Dev. 12:1610-1620.
22. Homanics, G.E., N.L. Harrison, J.J. Quinlan, M.D. Krasowski, C.E. Rick, A.L. de Blas, A.K. Mehta, F. Kist, R.M. Mihalek, J.J. Aul, and L.L. Firestone. 1999. Normal electrophysiological and behavioral responses to ethanol in mice lacking the long splice variant of the gamma2 subunit of the gamma-aminobutyrate type A receptor. Neuropharmacology. 38:253-265.
23. Hynes, R.O. 1990. Fibronectins. Springer-Verlag New York Inc., New York. 544 pp.
24. Jarnagin, W.R., D.C. Rockey, V.E. Koteliansky, S.S. Wang, and D.M. Bissell. 1994. Expression of variant fibronectins in wound healing: cellular source and biological activity of the EIIIA segment in rat hepatic fibrogenesis. J. CelI Biol. 127:2037-2048.
25. Kornblihtt, A.R., and A. Gutman. 1988. Molecular biology of the extracellular matrix proteins. Biol. Rev. Camb. Philos. Soc. 63:465-507.
26. Kornblihtt, A.R., K. Vibe-Pedersen, and F.E. Baralle. 1983. Isolation and characterization of cDNA clones for human and bovine fibronectins. Proc. Natl. Acad. Sci. USA. 80:3218-3222.
27. Kornblihtt, A.R., K. Vibe-Pedersen, and F.E. Baralle. 1984. Human fibronectin: molecular cloning evidence for two mRNA species differing by an internal segment coding for a structural domain. EMBO J. 3:221-226.
28. Kornblihtt, A.R., C.G. Pesce, C.R. Alonso, P. Cramer, A. Srebrow, S. Werbajh, and A.F. Muro. 1996. The fibronectin gene as a model for splicing and transcription studies. FASEB J. 10:248-257.
29. Kunstyr, I., and H.G. Leuenberger. 1975. Gerontological data of C57BL/6J mice. I. Sex differences in survival curves. J. Gerontol. 30:157-162.
30. Kwan, K.Y., and J.C. Wang. 2001. Mice lacking DNA topoisomerase IIIbeta develop to maturity but show a reduced mean lifespan. Proc. Natl. Acad. Sci. USA. 98:5717-5721.
31. Lavigueur, A., H. La Branche, A.R. Kornblihtt, and B. Chabot. 1993. A splicing enhancer in the human fibronectin alternate ED1 exon interacts with SR proteins and stimulates U2 snRNP binding. Genes Dev. 7:2405-2417.
32. Lewandoski, M. 2001. Conditional control of gene expression in the mouse. Nat. Rev. Genet. 2:743-755.
33. Liao, Y.F., P.J. Gotwals, V.E. Koteliansky, D. Sheppard, and L. Van De Water. 2002. The EIIIA segment of fibronectin is a ligand for integrins alpha 9beta 1 and alpha 4beta 1 providing a novel mechanism for regulating cell adhesion by alternative splicing. J. Biol. Chem. 277:14467-14474.
34. Lim, L.P., and P.A. Sharp. 1998. Alternative splicing of the fibronectin EIIIB exon depends on specific TGCATG repeats. Mol. Cell. Biol. 18:3900-3906.
35. Magnuson, V.L., M. Young, D.G. Schattenberg, M.A. Mancini, D.L. Chen, B. Steffensen, and R.J. Klebe. 1991. The alternative splicing of fibronectin pre-mRNA is altered during aging and in response to growth factors. J. Biol. Chem. 266:14654-14662.
36. Manabe, R., N. Oh-e, and K. Sekiguchi. 1999. Alternatively spliced EDA segment regulates fibronectin-dependent cell cycle progression and mitogenic signal transduction. J. Biol. Chem. 274:5919-5924.
37. Manabe, R., N. Ohe, T. Maeda, T. Fukuda, and K. Sekiguchi. 1997. Modulation of cell-adhesive activity of fibronectin by the alternatively spliced EDA segment. J. Cell Biol. 139:295-307.
38. Mardon, H.J., G. Sebastio, and F.E. Baralle. 1987. A role for exon sequences in alternative splicing of the human fibronectin gene. Nucleic Acids Res. 15:7725-7733.
39. Muro, A.F., A. Iaconcig, and F.E. Baralle. 1998. Regulation of the fibronectin EDA exon alternative splicing. Cooperative role of the exonic enhancer element and the 5′ splicing site. FEBS Lett. 437:137-141.
40. Muro, A.F., M. Caputi, R. Pariyarath, F. Pagani, E. Buratti, and F.E. Baralle. 1999. Regulation of fibronectin EDA exon alternative splicing: possible role of RNA secondary structure for enhancer display. Mol. Cell. Biol. 19:2657-2671.
41. Okamura, Y., M. Watari, E.S. Jerud, D.W. Young, S.T. Ishizaka, J. Rose, J.C. Chow, and J.F. Strauss III. 2001. The extra domain A of fibronectin activates Toll-like receptor 4. J. Biol. Chem. 276:10229-10233.
42. Oyama, F., Y. Murata, N. Suganuma, T. Kimura, K. Titani, and K. Sekiguchi. 1989. Patterns of alternative splicing of fibronectin pre-mRNA in human adult and fetal tissues. Biochemistry. 28:1428-1434.
43. Pagani, F., L. Zagato, C. Vergani, G. Casari, A. Sidoli, and F.E. Baralle. 1991. Tissue-specific splicing pattern of fibronectin messenger RNA precursor during development and aging in rat. J. Cell Biol. 113:1223-1229.
44. Peters, D.M., L.M. Portz, J. Fullenwider, and D.F. Mosher. 1990. Coassembly of plasma and cellular fibronectins into fibrils in human fibroblast cultures. J. Cell Biol. 111:249-256.
45. Petersen, T.E., H.C. Thogersen, K. Skorstengaard, K. Vibe-Pedersen, P. Sahl, L. Sottrup-Jensen, and S. Magnusson. 1983. Partial primary structure of bovine plasma fibronectin: three types of internal homology. Proc. Natl. Acad. Sci. USA. 80:137-141.
46. Sakai, T., K.J. Johnson, M. Murozono, K. Sakai, M.A. Magnuson, T. Wieloch, T. Cronberg, A. Isshiki, H.P. Erickson, and R. Fassler. 2001. Plasma fibronectin supports neuronal survival and reduces brain injury following transient focal cerebral ischemia but is not essential for skin-wound healing and hemostasis. Nat. Med. 7:324-330.
47. Satoi, S., Y. Hiramatsu, H. Kitade, A.H. Kwon, K. Matsui, K. Miyashita, E. Sakashita, K. Sekiguchi, H. Takahashi, and Y. Kamiyama. 1999. Different responses to surgical stress between extra domain A+ and plasma fibronectins. Clin. Exp. Pharmacol. Physiol. 26:225-229.
48. Schwarzbauer, J.E., J.W. Tamkun, I.R. Lemischka, and R.O. Hynes. 1983. Three different fibronectin mRNAs arise by alternative splicing within the coding region. Cell. 35:421-431.
49. Schwarzbauer, J.E., R.S. Patel, D. Fonda, and R.O. Hynes. 1987. Multiple sites of alternative splicing of the rat fibronectin gene transcript. EMBO J. 6:2573-2580.
50. Schwarzbauer, J.E., C.S. Spencer, and C.L. Wilson. 1989. Selective secretion of alternatively spliced fibronectin variants. J. Cell Biol. 109:3445-3453.
51. Singh, S., R. Mishra, N.A. Arango, J.M. Deng, R.R. Behringer, and G.F. Saunders. 2002. Iris hypoplasia in mice that lack the alternatively spliced Pax6(5a) isoform. Proc. Natl. Acad. Sci. USA. 99:6812-6815.
52. Smith, G.S., R.L. Walford, and M.R. Mickey. 1973. Lifespan and incidence of cancer and other diseases in selected long-lived inbred mice and their F 1 hybrids. J. Natl. Cancer Inst. 50:1195-1213.
53. Sternlicht, M.D., and Z. Werb. 2001. How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell Dev. Biol. 17:463-516.
54. Tamkun, J.W., and R.O. Hynes. 1983. Plasma fibronectin is synthesized and secreted by hepatocytes. J. Biol. Chem. 258:4641-4647.
55. Usiello, A., J.H. Baik, F. Rouge-Pont, R. Picetti, A. Dierich, M. LeMeur, P.V. Piazza, and E. Borrelli. 2000. Distinct functions of the two isoforms of dopamine D2 receptors. Nature. 408:199-203.
56. Wang, A., D.S. Cohen, E. Palmer, and D. Sheppard. 1991. Polarized regulation of fibronectin secretion and alternative splicing by transforming growth factor. J. Biol. Chem. 266:15598-15601.
57. Wang, Y., R. Xu, T. Sasaoka, S. Tonegawa, M.P. Kung, and E.B. Sankoorikal. 2000. Dopamine D2 long receptor-deficient mice display alterations in striatum-dependent functions. J. Neurosci. 20:8305-8314.
58. Xia, P., and L.A. Culp. 1995. Adhesion activity in fibronectin's alternatively spliced domain EDa (EIIIA): complementarity to plasma fibronectin functions. Exp. Cell Res. 217:517-527.
59. Yoo, J.Y., D.L. Huso, D. Nathans, and S. Desiderio. 2002. Specific ablation of Stat3beta distorts the pattern of Stat3-responsive gene expression and impairs recovery from endotoxic shock. Cell. 108:331-344.
60. Zardi, L., B. Carnemolla, A. Siri, T.E. Petersen, G. Paolella, G. Sebastio, and F.E. Baralle. 1987. Transformed human cells produce a new fibronectin isoform by preferential alternative splicing of a previously unobserved exon. EMBO J. 6:2337-2342.